Effect of induction chemotherapy on speech and swallowing function in patients with oral tongue cancer.

Merrill S Kies, Erich M Sturgis, Jan S Lewin, Denise A Barringer, Katherine A Hutcheson

Journal: Head & neck 2009;31(5):611-7

PMID: 19107949

Free Full Text on PubMed Central View on PubMed

Abstract

BACKGROUND

Swallowing physiology, diet, and patient-reported outcomes were evaluated after induction chemotherapy for oral tongue cancer.

METHODS

Fifteen of 23 patients enrolled in a phase II clinical trial of induction chemotherapy followed by surgical resection for oral tongue cancer underwent instrumental and perceptual analysis of speech and swallowing. Oropharyngeal swallow efficiency (OPSE) was calculated. Patient-reported outcomes were collected. We compared pre- and postchemotherapy results.

RESULTS

OPSE scores were not significantly different (p > .05) after induction chemotherapy; however, patient-reported swallowing and diet levels were significantly higher (p < .001 and p = .015, respectively). Diet levels improved from soft-chewable to full diet in most patients. Speech intelligibility did not change (p = .328).

CONCLUSION

It appears that induction chemotherapy has a negligible effect on speech and swallowing physiology but may provide symptomatic improvement of pain and swallowing after treatment. Further investigations are needed to corroborate these findings.

Address: Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

DOI: 10.1002/hed.20989

Link outs

Free resources

Full Text Sources:

Medical:

https://clinicaltrials.gov/search?term=AREA%5BRefe...

Subscription / membership required

Full Text Sources:

MeSH Terms: Adult, Antineoplastic Agents, Barium Sulfate, Carboplatin, Carcinoma, Squamous Cell, Contrast Media, Deglutition, Diet, Female, Humans, Male, Middle Aged, Pain Measurement, Prospective Studies, Quality of Life, Speech Intelligibility, Speech Production Measurement, Surveys and Questionnaires, Tongue Neoplasms